Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007382-23
Application #
2857617
Study Section
Special Emphasis Panel (ZHL1-CSR-Y (F1))
Project Start
1978-07-01
Project End
2003-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
23
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Zhou, Long; Hinerman, Jennifer M; Blaszczyk, Michal et al. (2016) Structural basis for collagen recognition by the immune receptor OSCAR. Blood 127:529-37
Bodi, Ilona; Nakayama, Hiroyuki; Schwartz, Arnold (2016) Tetrodotoxin-sensitive Ca2+ Currents, but No T-type Currents in Normal, Hypertrophied, and Failing Mouse Cardiomyocytes. J Cardiovasc Pharmacol 68:452-464
Deng, Xiaodi; Walker, Ryan G; Morris, Jamie et al. (2015) Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function. J Biol Chem 290:10689-702
Waltmann, Meaghan D; Basford, Joshua E; Konaniah, Eddy S et al. (2014) Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis. Biochim Biophys Acta 1842:1395-405
McLendon, Patrick M; Ferguson, Bradley S; Osinska, Hanna et al. (2014) Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy. Proc Natl Acad Sci U S A 111:E5178-86
Koch, Sheryl E; Tranter, Michael; Robbins, Nathan et al. (2013) Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model. J Cardiovasc Pharmacol Ther 18:280-9
Deng, Xiaodi; Morris, Jamie; Chaton, Catherine et al. (2013) Small-angle X-ray scattering of apolipoprotein A-IV reveals the importance of its termini for structural stability. J Biol Chem 288:4854-66
Pritchard, Tracy J; Kawase, Yoshiaki; Haghighi, Kobra et al. (2013) Active inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts. PLoS One 8:e80717
Schulz, Emily M; Wieczorek, David F (2013) Tropomyosin de-phosphorylation in the heart: what are the consequences? J Muscle Res Cell Motil 34:239-46
Schulz, Emily M; Wilder, Tanganyika; Chowdhury, Shamim A K et al. (2013) Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy. J Biol Chem 288:28925-35

Showing the most recent 10 out of 154 publications